After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

Pharmaceutical drugs approved by the Food and Drug Administration (FDA) but later re-called from the market—such as the antidiabetic drug Avandia and pain-reliever Vioxx—were the impetus for an Institute of Medicine committee report released yesterday, recommending that the FDA take proactive steps to continue monitoring drugs' safety after initial approval and throughout their time on the market.

To relieve pain, arthritis sufferers are prescribed medications that may include non-steroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX-2) inhibitors, both of which can irritate the digestive tract.

Leading litigation firm gears up to take on manufacturer of popular diabetes drug. Alton, IL (PRWEB) January 25, 2012 The Judicial Panel on Multi-District

Ennis & Ennis, P.A.